SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031066
Filing Date
2023-11-09
Accepted
2023-11-09 07:01:00
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr20230930_10q.htm   iXBRL 10-Q 910785
2 EXHIBIT 31.1 ex_563917.htm EX-31.1 13265
3 EXHIBIT 31.2 ex_563918.htm EX-31.2 13250
4 EXHIBIT 32.1 ex_563919.htm EX-32.1 8440
10 mnpr_10qimg6.jpg GRAPHIC 16242
  Complete submission text file 0001437749-23-031066.txt   3987085

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20230930.xsd EX-101.SCH 31293
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20230930_cal.xml EX-101.CAL 21288
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20230930_def.xml EX-101.DEF 219231
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20230930_lab.xml EX-101.LAB 214953
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20230930_pre.xml EX-101.PRE 238277
42 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20230930_10q_htm.xml XML 572033
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 231389983
SIC: 2834 Pharmaceutical Preparations